Literature DB >> 6492278

Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy.

H Wijkström, H Gustafson, B Tribukait.   

Abstract

Analysis of cellular deoxyribonucleic acid content via flow cytometry was done on tumor biopsies and bladder washings from 61 patients with transitional cell carcinoma who underwent preoperative irradiation (36 or 20 Gy) and cystectomy. Classification only of tumors as diploid or various forms of aneuploid did not facilitate the separation of these advanced tumors into different subgroups. In addition, the proliferation rates, which also were high, did not facilitate further subclassification. On the other hand, more than 1 aneuploid cell line in the preoperative biopsies was linked more closely to pathological than to clinical stage and was found particularly if the stage was unchanged or increased after irradiation. The deoxyribonucleic acid pattern generally was the same after irradiation in patients with residual tumor and persistent aneuploidy. However, a diploid deoxyribonucleic acid value was noted in a number of patients with residual tumors, which indicated the existence of diploid and aneuploid tumor cells, and a preferential irradiation effect on the aneuploid portion of the tumor cell population.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492278     DOI: 10.1016/s0022-5347(17)49936-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.

Authors:  C E Blomjous; N W Schipper; J P Baak; E M van Galen; H J de Voogt; C J Meyer
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

2.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988

3.  Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?

Authors:  P J Finan; P Quirke; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.